ZURA

Conviction 86HealthcareScan · Mon, Aug 10, 2026

ZURA$5.64-5.53%

ResistanceSupportVol 14

Vol MA14 951.26K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Zura Bio LtdBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.zurabio.com ↗

Price5.64

Change-5.53%

Gap-1.51%

Rel volume9.84×

Avg volume888.28K

Avg $ vol4.91M

SMA 205.47

SMA 504.83

SMA 2005.05

Price vs 50+16.60%

Price vs 200+11.55%

MA stackmixed

50/200 cross—

Supertrendup · 4.83

RSI (14)55

MACD hist0.00

MACD crossbull · 1d

Stoch %K / %D58 / 77

ADX (14)26

+DI / −DI21 / 12

RSI divergence—

MACD divergence—

ATR %+6.39%

ADR %6.18%

52w high7.04

52w low1.41

From 52w high-19.96%

Above 52w low+299.65%

New 52w highNo

SqueezeOn · 10d

Bollinger width15.18%

%B0.70

Donchian pos64.95%

Donchian high6.01

Donchian low4.94

AVWAP (52w high)5.04

vs AVWAP high+11.76%

AVWAP (52w low)4.47

vs AVWAP low+26.07%

OBV trendDown

Chaikin MF (20)-0.17

Today vs 20d9.84×

Avg vol (14d)951.26K

Avg vol (20d)888.28K

Avg $ vol (20d)4.91M

Market cap535.31M

RS 3m (vs SPY)+25.69%

RS 6m (vs SPY)-8.91%

RS line new highNo

Trend template7/8

Technical rank59.9

1 week+2.08%

1 month+10.27%

3 months+17.64%

6 months-6.24%

1 year+280.74%

YTD+1.53%

P/E-7.80

P/B5.27

P/S—

P/FCF-8.24

EPS-1.06

Div yield—

ROE-67.61%

ROA-30.03%

Debt/Eq—

Current19.33

EV/EBITDA-4.12

Gross margin—

Net margin—

Rev growth—

EPS growth-31.00%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value309.72M

Revenue—

Net income-24.22M

Gross profit—

Free cash flow-64.93M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out95M

Employees40

ListedTue, Mar 21, 2023

Free float52.02M

Float %54.8%

Short interest10.25M

Days to cover9.5d

Short volume29.2%

Squeeze score79 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction86 / 100

Pattern quality—

Tech rank59.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.88

Support4.18

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZURA

All disclosures →

No recent disclosed trades by Congress in ZURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZURA · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Thiara Parvinder Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Schoch Steven J Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Nirula Ajay Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Eisner Mark Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Jarrett Jennifer Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Munshi Amit Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22
Becker Daniel J. Director · Share Option (Right to Buy) · 2026-06-17	Grant	51K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in ZURA · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.